Subscribe to RSS
DOI: 10.1055/s-2003-43341
A Model Route Toward the Synthesis of Conformationally Constrained Polyhydroxylated Dipeptides from Natural Carbohydrates
Publication History
Publication Date:
21 November 2003 (online)
Abstract
Enantiopure 6,7-diacetoxy-3-t-butoxycarbonylamino-azabicyclo[3.3.0]octan-2-one-8-carboxylic acid 14 (pyrrolizidinone amino acid) was synthesized in 14 steps and 5.8% overall yield from tri-O-benzyl-d-arabinose 5 through the formyl C-iminosugar 9 as a key intermediate.
Key words
integrins - peptidomimetics - pyrrolizidinone amino acids - reverse-turn - RGD
-
1a
Olson GL.Bolin DR.Bonner MP.Bös M.Cook CM.Fry DC.Graves BJ.Hatada M.Hill DE.Kahn M.Madison VS.Rusiecki VK.Sarabu R.Sepinwall J.Vincent GP.Voss ME. J. Med. Chem. 1993, 36: 3039 -
1b
Gante J. Angew. Chem., Int. Ed. Engl. 1994, 33: 1699 -
2a
Peptide Secondary Structure Mimetics In Tetrahedron Symposia-in-Print
Vol. 49:
Kahn M. Elsevier; Amsterdam: 1993. p.3433-3689 -
2b
Hanessian S.McNaughton-Smith G.Lombart H.-G.Lubell WD. Tetrahedron 1997, 53: 12789 ; and references cited therein -
3a
Halab L.Gosselin F.Lubell WD. Biopolymers 2000, 55: 101 -
3b
Dietrich E.Lubell WD. J. Org. Chem. 2003, 68: 6988 -
4a
Gillespie P.Cicariello J.Olson GL. Biopolymers 1997, 43: 191 -
4b
Takeuchi Y.Marshall GR. J. Am. Chem. Soc. 1998, 120: 5363 -
4c
Belvisi L.Bernardi A.Manzoni L.Potenza D.Scolastico C. Eur. J. Org. Chem. 2000, 2563 -
5a
Lombart H.-G.Lubell WD. J. Org. Chem. 1994, 59: 6147 -
5b
Lombart H.-G.Lubell WD. J. Org. Chem. 1996, 61: 9437 -
6a
Polyak F.Lubell WD. J. Org. Chem. 2001, 66: 1171 -
6b
Feng Z.Lubell WD. J. Org. Chem. 2001, 66: 1181 -
6c
Artale E.Banfi G.Belvisi L.Colombo L.Colombo M.Manzoni L.Scolastico C. Tetrahedron 2003, 59: 6241 -
7a
Hruby VJ.Li G.Haskell-Luevano C.Shenderovich M. Biopolymers 1997, 43: 219 -
7b
Wang W.Yang J.Ying J.Xiong C.Zhang J.Cai C.Hruby VJ. J. Org. Chem. 2002, 67: 6353 -
8a
Gosselin F.Lubell WD. J. Org. Chem. 1998, 63: 7463 -
8b
Angiolini M.Araneo S.Belvisi L.Cesarotti E.Checchia A.Crippa L.Manzoni L.Scolastico C. Eur. J. Org. Chem. 2000, 2571 -
8c
Gosselin F.Lubell WD. J. Org. Chem. 2000, 65: 2163 -
9a
Haubner R.Schmitt W.Hölzemann G.Goodman SL.Jonczyk A.Kessler H. J. Am. Chem. Soc. 1996, 118: 7881 -
9b
Belvisi L.Bernardi A.Checchia A.Manzoni L.Potenza D.Scolastico C.Castorina M.Cupelli A.Giannini G.Carminati P.Pisano C. Org. Lett. 2001, 3: 1001 -
9c
Marinelli L.Lavecchia A.Gottschalk K.-E.Novellino E.Kessler H. J. Med. Chem. 2003, 46: 4393 -
10a
Haubner R.Finsinger D.Kessler H. Angew. Chem. Int. Ed. 1997, 36: 1374 -
10b
Gottschalk K.-E.Kessler H. Angew. Chem. Int. Ed. 2002, 41: 3767 -
10c
Hynes RO. Nature Med. 2002, 8: 918 - 11 Another class of conformationally constrained polyhydroxylated dipeptides has been recently described, see:
Tremmel P.Brand J.Knapp V.Geyer A. Eur. J. Org. Chem. 2003, 878 - 12
Arap W.Pasqualini R.Ruoslahti E. Science 1998, 279: 377 - Compound 6 was prepared in gram scale quantities by stereoselective addition of 2-lithiothiazole to the nitrone derived from d-arabinose 5 followed by dehydroxylation of the resulting open-chain hydroxylamine and cyclization by intramolecular nitrogen-carbon bond formation via SN2 process. See:
-
13a
Dondoni A.Perrone D. Tetrahedron Lett. 1999, 40: 9375 -
13b
Dondoni A.Giovannini P.Perrone D. J. Org. Chem. 2002, 62: 7203 - 15
Dondoni A.Marra A.Scherrmann M.-C.Bertolasi V. Chem.-Eur. J. 2001, 7: 1371 - 16
Schmidt U.Lieberknecht A.Wild J. Synthesis 1984, 53 - 18 Unnatural hetero-bifunctional ligands bearing the sialyl Lewis oligosaccharide and the RGD peptide sequence have been recently prepared, see:
Matsuda M.Nishimura S.-I.Nakajima F.Nishimura T. J. Med. Chem. 2001, 44: 715 - The LDT-mediated binding between the mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and its receptor, the α4β7 integrins, is responsible for the lymphocytes recruitment to inflamed colon. Cyclic peptidomimetics containing the LDT motif are inhibitors of this recognition process and therefore may lead to a new, organ specific treatment of inflammatory diseases.
-
19a
Gottschling D.Boer J.Schuster A.Holzmann B.Kessler H. Angew. Chem. Int. Ed. 2002, 41: 3007 -
19b
Gottschling D.Boer J.Marinelli L.Voll G.Haupt M.Schuster A.Holzmann B.Kessler H. ChemBioChem 2002, 575
References
Compound 7. [α]D = +22.2 (c 1.2, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 7.74 (d, J = 3.3 Hz, 1 H, Th), 7.32-7.14 (m, 16 H, 3 × Ph, Th), 4.68, 4.50 (2 × d, 2 H, J = 11.7 Hz, PhCH 2O), 4.58, 4.46 (2 × d, J = 11.7 Hz, 2 H, PhCH 2O), 4.44 (d, J 2,3 = 4.8 Hz, 1 H, H-2), 4.27 (dd, J 3,4 = 4.5 Hz, 1 H, H-3), 4.16 (dd, J 4,5 = 6.6 Hz, 1 H, H-4), 4.01, 3.82 (2 × d, J = 13.7 Hz, 2 H, PhCH 2N), 3.63 (dd, J 5,6 = 4.5 Hz, J 6,OH = 6.3 Hz, 2 H, 2 × H-6), 3.34 (dt, 1 H, H-5), 2.65 (t, 1 H, OH). Compound 8. [α]D = +35.5 (c 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.68 (d, J = 3.3 Hz, 1 H, Th), 7.38-7.17, 7.00-6.96 (2 × m, 16 H, 3 × Ph, Th), 6.81-6.72 (m, 4 H, MeOPh), 4.69, 4.54 (2 × d, J = 11.8 Hz, 2 H, PhCH 2O), 4.46 (d, J 2,3 = 2.5 Hz, 1 H, H-2), 4.37, 4.31 (2 × d, J = 11.9 Hz, 2 H, PhCH 2O), 4.29 (dd, J 3,4 = 2.3 Hz, 1 H, H-3), 4.17 (dd, J 5,6a = 7.1 Hz, J 6a,6b = 9.0 Hz, 1 H, H-6a), 4.12 (dd, J 4,5 = 5.6 Hz, 1 H, H-4), 4.08, 3.99 (2 × d, J = 13.6 Hz, 2 H, PhCH 2N), 3.92 (dd, J 5,6b = 5.1 Hz, 1 H, H-6b), 3.77 (s, 3 H, Me), 3.67 (ddd, 1 H, H-5). Compound 9. [α]D = +2.5 (c 0.6, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 9.30 (d, J = 1.3 Hz, 1 H, CHO), 7.40-7.20, 7.16-7.11 (2 × m, 15 H, 3 × Ph), 6.84 (s, 4 H, MeOPh), 4.59, 4.51 (2 × d, J = 11.8 Hz, 2 H, PhCH 2O), 4.44, 4.28 (2 × d, J = 11.7 Hz, 2 H, PhCH 2O), 4.29 (dd, J 5,6a = 7.7 Hz, J 6a,6b = 9.3 Hz, 1 H, H-6a), 4.27, 3.76 (2 × d, J = 13.2 Hz, 2 H, PhCH 2N), 4.11 (dd, J 2,3 = 1.2 Hz, J 3,4 = 1.5 Hz, 1 H, H-3), 4.10 (dd, J 4,5 = 4.3 Hz, 1 H, H-4), 4.09 (dd, J 5,6b = 5.3 Hz, 1 H, H-6b), 3.78 (s, 3 H, Me), 3.68 (ddd, 1 H, H-5), 3.38 (dd, 1 H, H-2). 13C NMR (100 MHz, CDCl3): δ = 204.7 (C-1), 153.9, 153.0, 115.4, 114.6 (MeOPh), 138.8, 137.5, 137.4, 129.1-127.5 (3 × Ph), 84.2 (C-3), 80.0 (C-4), 76.2 (C-2), 71.8 (PhCH2O), 71.4 (PhCH2O), 67.2 (C-6), 66.2 (C-5), 60.7 (PhCH2N), 55.8 (MeO).
17Compound 11. [α]D = -8.7 (c 0.8, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.34-7.18 (m, 20 H, 4 × Ph), 7.08 (br s, 1 H, NH), 6.81-6.72 (m, 4 H, MeOPh), 6.21 (d, J = 8.2 Hz, 1 H, CH=), 5.09, 5.01 (2 × d, J = 12.3 Hz, 2 H, PhCH
2OCO), 4.51, 4.46 (2 × d, J = 11.8 Hz, 2 H, PhCH
2O), 4.45 (s, 2 H, PhCH
2O), 4.12 (dd, J
5,6a = 7.2 Hz, J
6a,6b = 9.4 Hz, 1 H, H-6a), 4.04 (dd, J
3,4 = 3.0 Hz, J
4,5 = 5.8 Hz, 1 H, H-4), 3.92 (dd,
J
5,6b = 4.7 Hz, 1 H, H-6b), 3.89, 3.80 (2 × d, J = 13.6 Hz,
2 H, PhCH
2N), 3.89 (dd, J
2,3 = 4.8 Hz, 1 H, H-3), 3.78, 3.71 (2 × s, 6 H, 2 × Me), 3.56 (dd, 1 H, H-2), 3.44 (ddd, 1 H, H-5). Compound 13. [α]D = -45.3 (c 0.4, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 6.86-6.79 (m, 4 H, MeOPh), 5.50 (dd, J
6,7 = J
7,8 = 7.7 Hz, 1 H, H-7), 5.19 (dd, J
5,6 = 7.3 Hz, 1 H, H-6), 4.94 (br d, J
3,NH = 5.5 Hz, 1 H, NH), 4.75 (dd,
J
8,9a = 3.9, J
9a,9b = 10.0 Hz, 1 H, H-9a), 4.44 (dd, J
3,4a = 6.9 Hz, J
3,4b = 12.1 Hz, 1 H, H-3), 4.28 (ddd, J
8,9b = 1.0 Hz, 1 H, H-8), 3.87 (dd, 1 H, H-9b), 3.76 (s, 3 H, Me), 3.64 (dd,
J
4a,5 = 5.3 Hz, J
4b,5 = 10.1 Hz, 1 H,, H-5), 2.96 (ddd,
J
4a,4b = 11.8 Hz, 1 H, H-4a), 2.10, 2.02 (2 × s, 6 H, 2 × Ac), 1.96 (ddd, 1 H, H-4b), 1.41 (s, 9 H, t-Bu). Compound epi
-13. [α]D = -34.9 (c 0.7, CHCl3). 1H NMR (400 MHz, CDCl3):
δ = 6.85-6.78 (m, 4 H, MeOPh), 5.52 (dd, J
6,7 = 7.8 Hz,
J
7,8 = 7.6 Hz, 1 H, H-7), 5.12 (dd, J
5,6 = 7.6 Hz, 1 H, H-6), 5.04 (br s, 1 H, NH), 4.69 (dd, J
8,9a = 4.6 Hz, J
9a,9b = 10.2 Hz, 1 H, H-9a), 4.28 (ddd, J
8,9b = 1.6 Hz, 1 H, H-8), 4.05-3.97 (m, 2 H, H-3, H-5), 3.94 (dd, 1 H, H-9b), 3.75 (s, 3 H, Me), 2.48 (ddd, J
3,4a = 7.6 Hz, J
4a,4b = 13.6, J
4a,5 = 9.5 Hz, 1 H, H-4a), 2.34 (ddd, J
3,4b = 2.2 Hz, J
4b,5 = 6.8 Hz, 1 H, H-4b), 2.10, 1.99 (2 × s, 6 H, 2 Ac), 1.42 (s, 9 H, t-Bu). Compound 14 Methyl Ester. [α]D =
-63.4 (c 0.3, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 5.61 (dd, J
6,7 = 9.3 Hz, J
7,8 = 8.2 Hz, 1 H, H-7), 5.10 (dd, J
5,6 = 8.4 Hz, 1 H, H-6), 5.08 (br d, J
3,NH = 7.0 Hz, 1 H, NH), 4.58 (d, 1 H, H-8), 4.53 (ddd, J
3,4a = 6.5 Hz, J
3,4b = 12.0 Hz, 1 H, H-3), 3.78 (s, 3 H, Me), 3.69 (ddd, J
4a,5 = 5.4 Hz, J
4b,5 = 9.5 Hz, 1 H, H-5), 3.02 (ddd, J
4a,4b = 12.5 Hz, 1 H, H-4a), 2.16 (ddd, 1 H, H-4b), 2.09, 2.06 (2 × s, 6 H, 2 × Ac), 1.43 (s, 9 H, t-Bu). 13C NMR (100 MHz, CDCl3): δ = 173.4 (Me3COCO), 173.3 (C-2), 170.4, 169.6 (CH3
CO), 167.8 (CO2Me), 80.1 (Me3
C), 75.7 (C-7), 75.3 (C-6), 57.7 (C-5), 56.5 (C-8), 54.3 (C-3), 52.8 (MeO), 38.8 (C-4), 28.3 (Me
3C), 20.6 and 20.3 (CH
3CO).